Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU
Sponsor: University Hospital, Toulouse
Summary
There would appear to be a strong interest in functional nuclear imaging for assessing the response to focal PaC treatment. Investigator team hypothesise that the diagnostic performance of PSMA PET is noninferior to that of MRI in detecting clinically significant recurrent PaC after treatment with HIFU. The main objective was to evaluate the diagnostic performance of PSMA PET compared with MRI with reference to the gold standard of prostate biopsy one year after HIFU.
Official title: Pilot Study Evaluating PSMA Positron Emission Tomography for Monitoring Clinically Significant Prostate Cancer After Focal HIFU Treatment
Key Details
Gender
MALE
Age Range
70 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-10
Completion Date
2028-10
Last Updated
2026-08-14
Healthy Volunteers
No
Interventions
Nuclear imaging (PSMA PET) with intravenous injection of a radiotracer one year after treatment (focal therapy)
Nuclear imaging (PSMA PET) with intravenous injection of a radiotracer p one year after treatment, multiparametric prostate MRI in accordance with current recommendations, follow-up prostate biopsy as part of routine care.
Locations (1)
University Hospital of Toulouse
Toulouse, France